La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Auteurs » - entrée « Paul J. Bédard »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Paul J. Bédaed < Paul J. Bédard < Paul J. Eslinger  Facettes :

List of bibliographic references indexed by Paul J. Bédard

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
002296 (2008) Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Fréderic Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Mehdi Dridi [Canada] ; Nancy Belanger [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys
002725 (2006) Pershia Samadi [Canada] ; Paul J. Bédard ; Claude RouillardOpioids and motor complications in Parkinson's disease.
002805 (2006) Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin
002806 (2006) Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: Effect on adenosine A2A receptors
002851 (2006) Pershia Samadi [Canada] ; Laurent Grégoire [Canada] ; Claude Rouillard [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] ; Daniel Lévesque [Canada]Docosahexaenoic acid reduces levodopa‐induced dyskinesias in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine monkeys
002B88 (2004) Abdallah Hadj Tahar [Canada] ; Laurent Grégoire ; Aurélie Darré ; Nancy Bélanger ; Leonard Meltzer ; Paul J. BédardEffect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys.
002D75 (2003) Frédéric Calon [Canada] ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di PaoloLevodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
003237 (2001) Frédéric Calon [Canada] ; Nadia Lavertu [Canada] ; Anne-Marie Lemieux [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of MPTP‐induced denervation on basal ganglia GABAB receptors: Correlation with dopamine concentrations and dopamine transporter
003512 (2000) Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Pierre J. Blanchet [Canada] ; Marc Morissette [Canada] ; Richard Grondin [Canada] ; Martin Goulet [Canada] ; Jean-Pierre Doucet [Canada] ; George S. Robertson [Canada] ; Eric Nestler [États-Unis] ; Thérèse Di Paolo [Canada] ; Paul J. Bédard [Canada]Dopamine-receptor stimulation: biobehavioral and biochemical consequences
003545 (2000) Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Pierre J. Blanchet ; Paul J. Bédard ; Thérèse Di Paolo125I-CGP 64213 Binding to GABAB Receptors in the Brain of Monkeys: Effect of MPTP and Dopaminomimetic Treatments
003672 (1999) Richard Grondin [Canada] ; Martin Goulet [Canada] ; Marc Morissette [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958
003681 (1999) Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Pierre J. Blanchet ; Paul J. Bédard ; Thérèse Di Paolo [Canada]Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABAA/benzodiazepine receptor complex and GABA content
003733 (1999) Martin Goulet ; Marc Morissette ; Richard Grondin ; Pierre Falardeau ; Paul J. Bédard ; William Rostène [France] ; Thérèse Di PaoloNeurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys
003890 (1998) Julien Doyon [Canada] ; Robert Laforce Jr. [Canada] ; Ginette Bouchard [Canada] ; Danielle Gaudreau [Canada] ; Joanne Roy [Canada] ; Marie Poirier [Canada] ; Paul J. Bédard [Canada] ; Fernand Bédard [Canada] ; Jean-Pierre Bouchard [Canada]Role of the striatum, cerebellum and frontal lobes in the automatization of a repeated visuomotor sequence of movements
003A98 (1997) Marc Morissette [Canada] ; Martin Goulet [Canada] ; Jean-Jacques Soghomonian [Canada] ; Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with l-DOPA therapy
003D21 (1996) Jean-Jacques Soghomonian [Canada] ; Sophie Pedneault [Canada] ; Pierre J. Blanchet [Canada] ; Martin Goulet [Canada] ; Thérèse Di Paolo [Canada] ; Paul J. Bédard [Canada]l-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys
003D48 (1996) Paul J. Bédard [Canada]Motor activity & movement disorders. Research issues and applications
003D77 (1996) Pierre J. Blanchet [Canada] ; Richard Grondin [Canada] ; Paul J. Bédard [Canada] ; Kazumi Shiosaki [États-Unis] ; Donald R. Britton [États-Unis]Dopamine D1 receptor desensitization profile in MPTP-lesioned primates
003F76 (1995) Céline Gagnon [Canada] ; Baltazar Gomez-Mancilla [Canada] ; Rudolf Markstein [Suisse] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors
004526 (1992) Baltazar Gomez-Mancilla [Canada] ; Paul J. Bédard [Canada]Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys
004899 (1990) Céline Gagnon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Paul J. Bédard" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Paul J. Bédard" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Paul J. Bédard
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022